On the other hand, a significant increase in production of IL-18 has been obtained from lipopolysaccharide (LPS)-stimulated blood mononuclear cells of AD patients, and that was particular in AD patients carrying the −607 C/C genotype of IL-18 promoter. The gene discussed is IL18; the disease is Alzheimer disease.